Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Deep learning-based prediction of HER2 status and trastuzumab treatment efficacy of gastric adenocarcinoma based on morphological features

Fig. 3

Average receiver operating characteristic (ROC) curve generated through the application of stratified 10-fold cross-validation for the surgical cohort (a), including the HER2 2 + dataset (b), with the corresponding ROC curves for the biopsy cohort shown (c); d, The box plot was generated by consolidating the test set scores obtained from each fold for the surgical cohort

Back to article page